Lactose (India) Ltd | 158 Cr. | 126 | 247/84.3 | 36.1 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
MPS Pharmaa Ltd | 3.80 Cr. | 1.99 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 4,263 Cr. | 391 | 425/192 | 95.6 | 22.8 | 0.17 % | 27.3 % | 21.7 % | 1.00 |
Gujarat Terce Laboratories Ltd | 31.3 Cr. | 42.2 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 29.3 Cr. | 20.0 | 29.1/17.0 | 30.6 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 66.3 Cr. | 88.0 | 142/79.0 | 17.5 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 55,763 Cr. | 1,976 | 2,286/1,275 | 41.8 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 269 Cr. | 11.8 | 24.7/10.8 | 16.3 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 611 Cr. | 1,294 | 1,356/635 | 26.1 | 299 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 110 Cr. | 22.1 | 32.0/15.0 | 33.8 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 960 Cr. | 326 | 449/219 | 9.18 | 123 | 0.76 % | 23.0 % | 24.9 % | 5.00 |
Fabino Enterprises Ltd | 5.09 Cr. | 24.2 | 39.0/22.8 | 39.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 10.8 Cr. | 4.36 | 9.28/2.11 | 121 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 392 Cr. | 404 | 477/112 | 63.1 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 4,709 Cr. | 1,083 | 1,584/1,068 | 45.9 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
Murae Organisor Ltd | 117 Cr. | 0.57 | 1.24/0.48 | 7.67 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 47.5 Cr. | 19.7 | 26.3/6.40 | 48.9 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 10.4 Cr. | 10.3 | 17.3/9.61 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
Coral Laboratories Ltd | 182 Cr. | 510 | 961/443 | 9.87 | 563 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 66.2 Cr. | 66.2 | 71.0/26.1 | 170 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 18.3 Cr. | 40.1 | 88.7/37.9 | 38.2 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 11.9 Cr. | 4.77 | 5.36/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 17.1 Cr. | 114 | 154/59.6 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
Checkpoint Trends Ltd | 25.7 Cr. | 47.0 | 47.0/9.41 | 285 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
Chandra Bhagat Pharma Ltd | 32.4 Cr. | 43.0 | 80.0/0.00 | 45.7 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
Brawn Biotech Ltd | 5.73 Cr. | 19.1 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
Blue Jet Healthcare Ltd | 11,204 Cr. | 646 | 1,028/464 | 31.2 | 65.3 | 0.19 % | 39.8 % | 30.2 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 91.4 Cr. | 21.2 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.4 Cr. | 22.4 | 46.0/17.4 | 49.4 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
BDH Industries Ltd | 251 Cr. | 436 | 464/241 | 26.3 | 119 | 1.03 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 57.9 Cr. | 40.4 | 62.6/28.8 | 52.2 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
Aurobindo Pharma Ltd | 63,867 Cr. | 1,090 | 1,530/994 | 18.8 | 557 | 0.41 % | 14.2 % | 11.1 % | 1.00 |
Auro Laboratories Ltd | 144 Cr. | 231 | 303/170 | 208 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 831 Cr. | 82.9 | 123/74.0 | 18.0 | 32.5 | 1.81 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 43.8 Cr. | 33.6 | 53.2/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
Acutaas Chemicals Ltd | 11,119 Cr. | 1,358 | 1,530/727 | 58.8 | 160 | 0.11 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.29 Cr. | 0.65 | 1.45/0.65 | 85.8 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 258 Cr. | 33.6 | 68.0/30.0 | 13.7 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 10.5 Cr. | 18.0 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 148 Cr. | 6.29 | 6.57/2.82 | 269 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 63,198 Cr. | 29,740 | 37,000/25,260 | 43.5 | 1,992 | 1.60 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 7,469 Cr. | 824 | 972/550 | 28.0 | 220 | 0.61 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 223 Cr. | 78.5 | 82.0/31.3 | 53.5 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 4,335 Cr. | 1,430 | 1,555/535 | | 78.1 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 21,717 Cr. | 1,336 | 1,870/915 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 811 Cr. | 247 | 330/154 | 18.9 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
Venus Remedies Ltd | 587 Cr. | 439 | 568/270 | 12.6 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,372 Cr. | 479 | 950/476 | 27.0 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,631 Cr. | 1,155 | 1,755/991 | 24.2 | 754 | 0.87 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,20,515 Cr. | 3,561 | 3,790/2,886 | 59.7 | 224 | 0.90 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,213 Cr. | 132 | 317/98.0 | | 43.7 | 0.38 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,559 Cr. | 16.6 | 24.0/14.1 | 27.4 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
Cohance Lifesciences Ltd | 33,257 Cr. | 869 | 1,360/856 | 94.6 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
Suven Life Sciences Ltd | 4,755 Cr. | 209 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,80,702 Cr. | 1,587 | 1,960/1,547 | 33.2 | 301 | 1.01 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,759 Cr. | 615 | 886/441 | 112 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,231 Cr. | 252 | 391/175 | 31.8 | 75.9 | 0.16 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 347 Cr. | 1,149 | 1,690/956 | 20.1 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
Shilpa Medicare Ltd | 7,548 Cr. | 772 | 1,003/530 | 58.7 | 243 | 0.06 % | 7.82 % | 4.21 % | 1.00 |
Sequent Scientific Ltd | 4,770 Cr. | 190 | 241/111 | 158 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 10,936 Cr. | 4,748 | 7,250/4,146 | 30.7 | 340 | 2.46 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,813 Cr. | 2,305 | 2,977/1,772 | 36.8 | 321 | 0.87 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,439 Cr. | 6,288 | 6,739/4,863 | 34.7 | 323 | 1.99 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 215 Cr. | 61.0 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 22,558 Cr. | 4,931 | 6,039/3,701 | 33.4 | 922 | 0.71 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 128 Cr. | 104 | 348/81.0 | 9.04 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
Panacea Biotec Ltd | 2,479 Cr. | 405 | 582/268 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,659 Cr. | 721 | 1,998/604 | 42.9 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
Neuland Laboratories Ltd | 17,918 Cr. | 13,966 | 18,100/10,060 | 136 | 1,188 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 323 Cr. | 14.4 | 46.0/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 14,700 Cr. | 821 | 1,505/660 | 8.66 | 425 | 0.73 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,678 Cr. | 48.9 | 94.5/41.7 | 28.9 | 21.1 | 0.41 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 7,449 Cr. | 164 | 359/162 | 21.3 | 54.4 | 0.49 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 114 Cr. | 72.2 | 142/65.5 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
Lyka Labs Ltd | 339 Cr. | 94.8 | 177/90.2 | 45.1 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
Lupin Ltd | 87,688 Cr. | 1,920 | 2,403/1,774 | 23.7 | 377 | 0.63 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,076 Cr. | 537 | 980/499 | 12.5 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
Laurus Labs Ltd | 44,930 Cr. | 832 | 944/423 | 88.2 | 84.6 | 0.14 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 937 Cr. | 903 | 1,235/596 | 21.6 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 153 Cr. | 71.0 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
Kopran Ltd | 839 Cr. | 174 | 340/154 | 24.0 | 107 | 1.73 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 596 Cr. | 341 | 500/265 | 21.3 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
Jubilant Pharmova Ltd | 16,613 Cr. | 1,043 | 1,310/802 | 34.2 | 393 | 0.48 % | 9.54 % | 9.55 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,153 Cr. | 1,670 | 1,998/1,303 | 38.2 | 221 | 0.93 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,432 Cr. | 215 | 328/158 | 33.6 | 36.1 | 1.16 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 34,788 Cr. | 1,371 | 1,758/1,168 | 38.9 | 274 | 0.29 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 3,049 Cr. | 104 | 127/57.5 | 29.0 | 57.5 | 0.77 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 734 Cr. | 99.9 | 134/67.2 | 33.3 | 194 | 0.00 % | 3.47 % | 3.50 % | 10.0 |
Indoco Remedies Ltd | 2,636 Cr. | 286 | 364/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
Hikal Ltd | 3,145 Cr. | 255 | 465/245 | 49.7 | 102 | 0.55 % | 9.85 % | 7.38 % | 2.00 |
Hester Biosciences Ltd | 1,635 Cr. | 1,922 | 2,786/1,243 | 43.5 | 369 | 0.36 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,590 Cr. | 358 | 504/285 | 58.7 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 12,519 Cr. | 516 | 628/412 | 26.2 | 153 | 0.29 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 55,642 Cr. | 1,972 | 2,286/1,275 | 41.8 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 45,272 Cr. | 2,672 | 3,516/1,921 | 47.8 | 115 | 1.57 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 32,261 Cr. | 1,958 | 2,131/1,200 | 28.4 | 592 | 0.92 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,394 Cr. | 454 | 570/359 | 27.5 | 140 | 1.10 % | 15.9 % | 11.8 % | 1.00 |
ERIS Lifesciences Ltd | 21,597 Cr. | 1,586 | 1,910/1,097 | 55.8 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,04,585 Cr. | 1,253 | 1,406/1,020 | 18.4 | 402 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,410 Cr. | 281 | 322/161 | 37.1 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
Cipla Ltd | 1,21,115 Cr. | 1,499 | 1,702/1,310 | 22.5 | 386 | 0.87 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,483 Cr. | 2,037 | 2,641/1,551 | 27.4 | 375 | 0.29 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 413 Cr. | 140 | 203/95.6 | 203 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,533 Cr. | 145 | 191/105 | 14.4 | 99.7 | 0.35 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 67.0 Cr. | 41.2 | 84.0/40.4 | 24.0 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 46,259 Cr. | 346 | 406/291 | 128 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,817 Cr. | 1,800 | 2,215/1,430 | 39.7 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
Bal Pharma Ltd | 135 Cr. | 84.9 | 141/76.3 | 18.9 | 48.6 | 1.41 % | 10.1 % | 9.66 % | 10.0 |
Bafna Pharmaceuticals Ltd | 420 Cr. | 176 | 176/67.8 | 41.7 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
Astrazeneca Pharma India Ltd | 22,313 Cr. | 8,925 | 10,691/6,220 | 106 | 308 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,110 Cr. | 730 | 843/544 | 38.7 | 113 | 0.64 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 192 Cr. | 91.0 | 145/85.0 | 7.28 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
Alkem Laboratories Ltd | 64,780 Cr. | 5,418 | 6,376/4,492 | 28.5 | 1,002 | 0.83 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 17,715 Cr. | 901 | 1,304/725 | 29.9 | 264 | 1.21 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 448 Cr. | 785 | 1,540/763 | 71.3 | 688 | 0.64 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 30,301 Cr. | 2,425 | 3,464/2,022 | 32.6 | 303 | 1.16 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,636 Cr. | 325 | 526/258 | 26.5 | 127 | 1.61 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,320 Cr. | 470 | 575/312 | 24.1 | 136 | 0.21 % | 13.5 % | 13.0 % | 10.0 |
Industry Average | 18,362.16 Cr | 1,145.27 | | 50.10 | 193.71 | 0.33% | 16.17% | 14.92% | 6.18 |